Cesarean Section Complications, Hypotension
Conditions
Keywords
noninvasive continuous blood pressure monitoring
Brief summary
Noninvasive continuous blood pressure monitoring for preventing post-spinal hypotension during cesarean delivery: A randomized controlled trial
Detailed description
The aim of this study was to find out whether the incidence of hypotension during surgery can be reduced in the case of non-invasive, continuous blood pressure monitoring using the ClearSight System in patients undergoing cesarean section under spinal anesthesia, compared to the case of using conventional noninvasive blood pressure monitoring
Interventions
Non-invasive, continuous blood pressure is monitored using ClearSight Sytem
Sponsors
Study design
Intervention model description
randomized double blind controlled trial
Eligibility
Inclusion criteria
* Adult mothers who are pregnant with single fetuses over 35 weeks gestational age undergoing planned cesarean delivery under spinal anesthesia
Exclusion criteria
* Multiple fetal pregnancy * Preexisting hypertension or pregnancy-induced hypertension * Underlying heart disease * Underlying cerebrovascular disease * Known fetal anomaly * Contraindicated in spinal anesthesia * Any sign of onset of labor * Body weight \<45 kg or body weight\> 90 kg * Height \<145cm or height\> 180cm * All other cases in which researchers determine to be inappropriate for this clinical trial
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Incidence of hypotension by individualized methods | From spinal anesthesia to delivery | Hypotension was defined as: SBP\<80% of baseline SBP |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Incidence of hypotension by standard methods | From spinal anesthesia to delivery | Hypotension was defined as MBP\<65mmHg |
| Time-weighted average SBP<80% of baseline SBP | From spinal anesthesia to delivery | Time-weighted average SBP\<80% of baseline SBP |
| Time-weighted average MAP <65mmHg | From spinal anesthesia to delivery | Time-weighted average MAP \<65mmHg |
| Incidence of intraoperative symptomatic hypotension | From spinal anesthesia to delivery | Defined as: hypotension plus nausea and/or vomiting and/or dizziness and/or breathlessness |
| Incidence of nausea, vomiting, dizziness, breathlessness | From spinal anesthesia to delivery | Incidence of nausea, vomiting, dizziness, breathlessness |
| Incidence of intraoperative Hypertension | From spinal anesthesia to delivery | SBP\> 120% of baseline SBP |
| Maximum, Minimum recorded SBP, DBP, MBP | From spinal anesthesia to delivery | Maximum, Minimum recorded SBP, DBP, MBP |
| Cumulative duration of hypotension | From spinal anesthesia to delivery | Cumulative duration of hypotension |
| Number of hypotensive episodes | From spinal anesthesia to delivery | Number of hypotensive episodes |
| Incidence of intraoperative severe hypotension | From spinal anesthesia to delivery | Defined as: SBP \< 70% of baseline SBP |
| Cumulative consumptions of vasopressors | From spinal anesthesia to delivery | Cumulative consumptions of vasopressors |
| Incidence of bradycardia | From spinal anesthesia to delivery | HR (heart rate) \<50 bpm |
| Incidence of atropine use | From spinal anesthesia to delivery | Incidence of atropine use |
| Minimum heart rate | From spinal anesthesia to delivery | Minimum heart rate |
| Cardiac output, stroke volume | From spinal anesthesia to delivery | only in ClearSight System group |
| The analysis of the differences between the test method (ClearSight) and reference method | From spinal anesthesia to delivery | Bland-Altman analysis |
| Apgar Score | at 1 minute after delivery and 5 minutes after delivery | 1 minute, 5 minutes |
| Umbilical arterial blood | within 10 minutes after delivery | Arterial blood gas analysis results |
| Umbilical arterial pH | within 10 minutes after delivery | \<7.2 |
| Onset time of hypotension | From spinal anesthesia to delivery | Onset time of hypotension |
Countries
South Korea